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Light me up: Power and Expertise in Risk 
Communication and Policy Making in the e-





This paper presents a detailed account of policymaking in a contemporary risk 
communication arena, where strong power dynamics are at play that have hitherto 
lacked theoretical analysis and empirical validation. Specifically, it expands on the 
understanding of how public health policy decisions are made when there is a weak 
evidential base and where multiple interpretations, power dynamics and values are 
brought to bear on issues of risk and uncertainty. The aim of the paper is to 
understand the role that power and expertise play in shaping public health risk 
communication within policy-related debates. By drawing on insight from 
interdisciplinary literature, the paper argues that there several interacting factors that 
shape how a particular narrative gains prominence within a wider set of perspectives 
and how the arguments and findings associated with that perspective become 
amplified within the context of policy choices. These findings are conceptualised 
into a new model - a policy evaluation risk communication (PERC) framework - and 







Risk communication processes are critical in shaping public understanding of health-
related risks (Bennett, 2010; Fischbacher-Smith, Irwin, & Fischbacher-Smith, 2010; 
Veland & Aven, 2013) and have become central to public health approaches in many 
countries, including United Kingdom (UK) (Alaszewski, 2005; de Jong, Ros, & 
Schrijvers, 2014; Plough et al., 2013). Risk communication is the exchange of risk 
information (resulting from both human and natural processes (Löfstedt, 2008; 
Veland & Aven, 2013)) between various stakeholder groups, such as government 
agencies, professional organizations, scientists, corporations and individual citizens 
(Covello, Slovic, & von Winterfeldt, 1986). Risk communication contributes 
significantly to shaping the public understanding of risk and influences the 
formulation of policy perspectives around managing risk (Fischbacher-Smith, 2012; 
Irwin, 2014; Smith, 1988; Stilgoe, 2007; Stilgoe, Irwin, & Jones, 2006; Welsh & 
Wynne, 2013; Wynne, 1996).  
 
To be effective, risk communication needs to be framed so that the encoding of the 
message allows for its effective decoding by its recipients (Bernstein, 1964; Fortune 
& Peters, 1995). Any failure to ensure that this process takes place, can lead to 
distortion in the message and a misunderstanding of the nature of risk and associated 
uncertainty. Within this context, powerful interest groups have sought to use their 
knowledge and expert resources in a bid to protect their interests in public health 
policy making by shaping the discourse around risk (Demeritt & Nobert, 2014; 
Hardy & Maguire, 2016; McKell & De Barro, 2016; Smith, 1988, 1990; Veland & 
Aven, 2013; Warner & Kinslow, 2013).  
 
This paper examines the processes of risk communication within the context of the 
electronic cigarette (vaping) debate within the UK. In particular, it considers how 
power and expertise shape public debates that involve a high degree of uncertainty 
and a requirement for an unambiguous burden of proof. Particular consideration is 
given to how policy decisions are made where there is a weak evidential base and 
where multiple interpretations, power dynamics and values are brought to bear on 
public health risk issues. The core of the paper examines how risk debates evolve 
such that a particular perspective becomes dominant in shaping policy. More 
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specifically, it explores how a risk argument evolves through the key stages of 
scientific verification and then policy formulation.  A theoretical framework is 
proposed that recognises the role of power in that process - the PERC (Policy 
Evaluation Risk Communication) framework – and is applied to the case of E-
Cigarettes.  
 
Perspectives on Risk Communication 
Literature on risk communication can be characterised by three overlapping 
perspectives: science and technology studies (STS), communication studies, and 
management (including risk and crisis management) (Irwin, 2014; Jasanoff, 2015; 
Renn, 2015; Stilgoe, 2016). These three perspectives correspond to Wardman 
(2008), “normative,” “instrumental,” and “substantive” imperatives that touch upon 
‘values’, ‘power’ and ‘co-production’ respectively in risk communication. This study 
draws upon these three disciplinary perspectives, although it is more inclined 
towards the management perspective, and subscribes to the view that risk 
communication is “a field of play and competition” (Bourdieu, 1998) between 
competing stakeholders’ interests (Petts et al., 2001; Pidgeon & Barnett, 2013). 
Stakeholders include: government agencies, professional organizations, scientists, 
corporations, non-governmental organisations and individual citizens (Covello et al., 
1986; Irwin, 1995). Each stakeholder seeks to frame the agenda in a way that serves 
their own interest and drives the communication dynamics of their own discourse 
(Murdock et al., 2003; Pidgeon & Barnett, 2013). Cognitive framing processes 
typically define the nature of the risk problem when establishing the source of the 
hazard, and suggesting policy solutions (Entman, 2014; Fischbacher-Smith et al., 
2010), typically in turn influencing the parameters of risk communication as 
essentially technocratic in scope and reliant on expert judgement.  
 
Unfortunately, this means that risk communication is often prone to abuse by 
powerful interest groups, especially where there is considerable uncertainty around 
the nature of the risk and where vested interests combine with unequal status 
between stakeholder groups (Collingridge & Reeve, 1986b; Smith, 1990). Such 
inequalities can create significant differences in the representations of the risks 
(Taghavifard, Damghani, & Moghaddam, 2009), especially in new and emergent 
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forms of activity where there is little or no prior scientific understanding of the 
nature of the hazards.  
 
Understanding risk is, therefore, a potentially double-edged process. Whilst the 
potential for harm in activities is often the dominant perspective of policy-makers, 
inadequacies or errors in understanding and framing risk can cause delays in 
developing appropriate policy interventions (Bero, 2003). In healthcare, these delays 
could potentially be lifesaving or life enhancing whilst errors in framing risk may 
result in policy interventions that do not reflect the available evidence, resulting in 
either over-regulation that could be costly and over-precautionary, or under-
regulation with resultant prolonged public exposure to health risks and danger 
(Diggle, 2010). The negative consequences can be heightened where there is 
considerable scientific uncertainty about the nature of the risk and its emerging 
properties, with associated impacts upon  sense making and the risk assessment 
process (Bennett, Calman, Curtis, & Fischbacher-Smith, 2010; Renn, 2008). 
Typically, it is the less powerful groups among larger sections of society who will 
bear the consequences of any errors in policy decisions.   
 
The Evolving Risk Debate – Public Concerns, Expert Speculation and Media 
Attention 
Concerns around public health, coupled with anecdotes and negative tales of 
personal experiences, often attract media attention (Bromley & Segerson, 2012) 
and create a wider awareness of the issues (Shih, Wijaya, & Brossard, 2008).  
Anecdotes, such as a doctor reporting an observation of an increase in incidences of 
lung cancer amongst smokers (Kasperson et al., 1988), can significantly shape 
public perceptions and policy perspectives towards the management of risk, even if 
only by providing hypotheses for scientific research (Moore and Stilgoe, 2009). 
Issue attention occurs where a risk issue suddenly becomes a focal point of media 
and public debate for a period of time, thereby creating political pressure for risk 
assessment (Downs, 1996). Gaps in the knowledge base or insufficient information 
are often addressed by seeking out potential sources of expertise (Kandlikar, 
Ramachandran, Maynard, Murdock, & Toscano, 2007). Technical expert 
judgements of risk are often deemed more credible than lay perspectives, because 
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of the legitimacy associated with their knowledge domain. However, when experts 
move outside of that knowledge domain, their ability to make ‘expert’ judgements 
is eroded. Thus, although many debates around risk are seen to be technical in their 
scope, there has been criticism of this technocratic view by those who see many of 
the interpretations about risk as social constructions where experts move outside of 
their knowledge domain (see, for example, Beck, 1986, 1992; Giddens, 1990; 
Nelkin, 1989; Stallings, 1990).  
 
Technical Debate 
Technical verification of a public health risk is essential for rationalising policy 
decisions and risk mitigating strategies that are already in place (Fischer, 1990, 
1998). Technical verification uses a scientific and evidence-based methodology in 
determining areas of known fact and determining their significance to public health 
and safety. Evidence from this process then shapes the state of knowledge but it can 
often struggle to deal with issues of emergence and the way that uncertainty is 
communicated. Emergence may therefore continually shift the requirement for a 
clear burden of proof amongst competing stakeholders. Problems may also arise 
from disciplinary differences because of epistemological and methodological 
differences with regard to facts, rigor, causal explanations and research goals 
(Collingridge & Reeve, 1986b). These differing paradigms may lead to different 
conclusions, thereby creating ambiguity and tension in how risk is identified and 
framed around policy debates. It is here that the dominant ideology and core belief 
of technical experts can combine with powerful interests to shape policy on the 
issue (Collingridge & Reeve, 1986a; Collingridge & Reeve, 1986b; Fischer, 1990).  
Collinridge and Reeve (1986a; 1986b) suggest that technical inputs into policy 
debates can either heighten conflict or create a sense of agreement about the issues. 
Science can therefore contribute to either an under-critical debate where there is no 
effective dialogue due to the role played by powerful interests in supressing 
opposing views, or an over-critical debate where there is perpetual conflict around 
the issues.  (Collingridge & Reeve, 1986b). The effect of science within the policy 
making process is thus determined by who has power to influence the policy 
process. Technical verification may in turn influence debates around risk 
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tolerability and acceptability. The core argument here is that risk assessment is not 
simply a matter of science as an objective analysis of evidence, rather, risk 
assessment  creates contexts within which statements and operations sound 
‘scientific’ and valid (Latour, 1987). The interaction and communication between 
certain stakeholders groups allow privileged access to exclusive information and 
policy makers, enabling them to discuss and express certain political opinions that 
can have powerful influences on policy-choices (Sutton, 1999). Policy framing of 
public health risk is essential as it is often followed by risk reduction actions (Korn, 
Gibbins, & Azmier, 2003) designed to bring about the desired behavioural 
responses.  
Figure 1 depicts the different stages of an evolving risk debate from initial anecdote 
to policy formulation. While Figure 1 shows a linear flow from public concern to 
policy debate, in reality, risk debates may begin at any stage and iterate, similarly 
public health risk arguments may emerge at all stages at the same time. Figure 1 
highlights the relationships between the technical evaluation of risk and policy 
debate and policy formation.  
 Figure 1: The different stages of risk debate 
  
The Policy Evaluation Risk Communication (PERC) Framework  
The Policy Evaluation Risk Communication (PERC) framework (see Figure 2) 
illustrates the factors that influence how policy-makers evaluate risk and 
uncertainty, especially where there are multiple perspectives, strong power 
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dynamics and values at play. The PERC framework assumes that the “social 
amplification of risk” (Kasperson et al., 1988; Renn, Burns, Kasperson, Kasperson, 
& Slovic, 1992) drives the transition of risk debates between the over critical and 
under critical models. The PERC framework identifies power, expertise, 
communication and trust as key factors shaping the amplification (or attenuation) 
of risk perspectives within the policy context. The framework also shows that the 
evolving nature of information, evidence and knowledge shapes how power, 
expertise, communication and trust are brought to bear on risk communication, and 
in turn further shape a risk argument. 
Figure 2: Policy Evaluation Risk Communication (PERC) framework  
 
  
Power: Policy arguments relating to risk are embedded within institutional, 
productive, structural and resistive forms of power, which means that power is fluid 
and creates imbalances in ways that enhance or inhibit certain stakeholder groups’ 
influence on risk communication. Power may be exercised by shaping the policy 
agenda (Bachrach & Baratz, 1962), controlling risk information and expertise 
(Lukes, 2005), establishing stakeholder relationships (Barnett & Duvall, 2005) and 
resisting dominant worldviews (Foucault, 1980). 
By shaping the risk agenda and prioritising policy objectives, policy makers and 
regulators are able to shape the direction of the risk debate and the issues that are 
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deliberated upon. The ability to control risk information, validate appropriate 
expertise and decide what, when or how much information or expertise is made 
available or concealed, may also drive the amplification (or attenuation) of certain 
policy arguments relating to risk. In addition, there is the power that comes with a 
stakeholder relationship that allows an exchange of views and political opinions 
and may generate a dominant hegemony within certain risk discourses. In addition, 
risk communication practices (Power, 2007) that view science as superior to other 
forms of knowledge and expertise and which shape how risk is accessed, 
interpreted and communicated are further avenues for social amplification (or 
attenuation) of public health risk.  
Expertise:  Another driver of the amplification (or attenuation) of risk within the 
policy domain is how experts interpret evidence, what constitutes evidence, and 
whose expertise is legitimised (Collingridge & Reeve, 1986b; Irwin, 1995). 
Research suggests that technical, rather than experiential expertise has more 
credibility and so technical expertise is often privileged within the policy context. 
However, several problems with the use of technical expertise have been identified 
as influencing how evidence is interpreted and risk signals framed. These include 
the domain specificity of expertise, the interdisciplinary nature of public health 
risk, the “paradigm blindness” (Fischbacher-Smith, 2012) that often influences how 
experts acknowledge challenges to their worldview, and the fact that technical 
expertise is socially constructed through established training and validation 
structures that can reinforce powerful and vested interests. It is therefore important 
that other forms of expertise are considered especially the experience of those who 
are in close proximity to the risk, in order to improve on the robustness of evidence 
(Stilgoe, 2007) and to ease the burden of proof (Fischbacher‐Smith & Fischbacher‐
Smith, 2009). 
Communication: How risk is communicated between various stakeholder groups is 
another factor that shapes risk amplification (Smith & Irwin, 1984; Smith & 
McCloskey, 1998). Using language relevant to all stakeholders involved in risk 
communication is essential in terms of translating the language of an expert in a 
way that is usable by decision or policy makers, while highlighting uncertainties 
where they exist (Adekola, Fischbacher-Smith, Fischbacher-Smith, & Adekola, 
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2017; Smith, 1990; Smith & McCloskey, 1998). The use of language where the 
receptor cannot decode the meaning reduces or amplifies the significance and use 
of any expert proposition.  
Also important is the quality of the feedback so that sensitive issues are addressed 
and dealt with appropriately: one-way risk communication may heighten tensions 
around risk acceptability, as it does not allow for clarification of meaning or 
discussion of sensitive issues. Furthermore, where the language of uncertainty is 
used, stakeholders have more scope to refute or undermine damaging arguments, 
speculations may increase, and the operating theories brought to bear on debates 
may push arguments towards an over critical model.  
 
Trust and credibility: Evidence from the literature has highlighted the importance 
of trust or perceived credibility of the source of risk information (Mayer et al., 
1995). The credibility of the source contributes to whether messages resonate with 
the audience (Frewer et al., 2003). Distrust contributes to heightened resistance in 
risk arguments that often leads to a distortion of the risk message. However, under 
circumstances where there is trust, the receiver of risk information may even 
become a walking and talking advertisement actively sharing the views of the other 
actors among his social network that may bring about hegemony of risk discourse 
in the policy domain. 
 
Information, evidence and knowledge: What is also important is how power, 
expertise, communication and trust are contingent upon the evolving nature of 
information, evidence and knowledge and how that can potentially shift risk 
arguments forward and backward between under critical and over-critical models  
(Fischbacher-Smith, 2012; Smith, 1990). As information, evidence and knowledge 
become available, it is possible that the uncertainty present in the discussions may 
decrease. This may result in a shift in the balance of power between the different 
stakeholders, alter how power and expertise are effected and in turn, influence the 
nature of communication and trust and how the public perceived risk 
communication.  
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Behavioural response to institutionalised policy perspective:  Policies that are 
designed to mitigate public health risk often prompt behavioural responses to 
perspectives about the nature of those risks. Significant response mechanisms are: 
the nature of social trust in policy makers and public health institutions (Renn & 
Levine, 1991), the ability of individuals or groups to resist a legitimised risk 
perspective, signal value (Kasperson, 2012), and the distribution of costs and 
benefits that can steer emotional responses to institutionalised policy perspectives 
(Adekola et al., 2017). Undesired behavioural responses or emergent problems may 
compel the government to change its policy and risk mitigating strategy. This is 
akin to Foucault’s resistive power (Foucault, 1982) but may not accompany change 
to deep core policy ideologies or beliefs (Sabatier & Jenkins‐Smith, 1993) in 
relation to the risk.  
Behavioural responses may also create unintended problems due to the emergent 
properties of risk, in turn giving rise to new areas of uncertainty, new research 
questions and challenges to existing policies. New research questions and new 
evidence following a technical verification may move risk arguments towards the 
over critical model and restarting the entire debate. The assumption made by the 
PERC framework is that policy debates relating to risk arise from, and are 
conducted within, a public space in which there are multiple interactions between 
power and expertise that enhance or inhibit risk communication. These interactions 
can also create or destroy trust and credibility, and privilege certain social and 
professional relationships over others. As such, a degree of bias can arise from the 
asymmetries of power underpinning these interactions and processes that in turn, 
perpetuate the domination of certain risk perspectives and/or shape the 
prioritisation of issues and debates in the policy domain. 
Methodology 
This paper draws on archival and documentary relating to E-cigarettes as a means of 
developing and applying the PERC framework.  The case is one of 3 employed in the 
full research study from which this paper derives.  The records allow examination of 
a chronology of the debate and insight into how communications took place and 
between whom; i.e. there is a breadth of coverage of events and contexts over time 
 12 
(Yin, 2011, 2013). Documentary data sources also help establish the validity of 
interpretations (Briggs, Morrison, & Coleman, 2012) within the cultural context in 
which they were generated (Briggs et al., 2012). Sources used include press releases, 
articles and media statements, official documents from government departments and 
organisations, reports from non-profit organisations, and scientific committee 
reports. 
In analysing the data, close attention was paid to the description and scope of 
published sources used, sampling frames, and summaries of data collection 
procedures. Document analysis was undertaken in light of established social science 
methods (Bowen, 2009) where the study of evolving events develops a sound 
understanding of a case study (Elo & Kyngäs, 2008). Evidence provided in this study 
is presented chronologically (Baxter & Jack, 2008; Sandelowski, 2000) allowing 
debates to be understood as they occur.  
 
The emergence of Vaping as an alternative to cigarettes 
The current debate around the safety of e-cigarettes (popularly known as vaping) 
emerged following the introduction of electronic cigarettes (EC) into the European 
market in 2006 in what was initially seen as a safer alternative to conventional 
cigarettes. However, in 2008, the World Health Organisation (WHO) raised concerns 
about the promotion of these “safer alternatives” because of the then under-
developed scientific understanding of their safety and efficacy (WHO, 2008).  In 
July 2009,  they raised further concerns that ECs were being targeted at young 
people and that EC packages lacked appropriate health warnings (CASSA, 2014).  
Thereafter, a series of industry-commissioned and other studies took place, each 
presenting differing accounts of the risks, thereby generating a contested 
environment around issues of safety.   
 
A report commissioned by EC manufacturer Ruyan, for example, reported ECs to be 
a safer alternative to conventional cigarettes with only trace toxins found to be 
contained within them (Laugesen, 2008). The report claim that ECs containing 
nicotine reduced the desire to smoke, were more pleasant to use than the nicotine 
inhalators, and performed significantly better than a placebo EC (Bullen et al., 2010). 
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Flouris and Oikonomou (2010) reviewed reports published by the US Food and 
Drugs Administration (FDA), Health New Zealand (HNZ), a private enterprise, and 
Demokritos, a publicly funded Greek research institute. The reports revealed similar 
findings in that they identified different harmful constituents of EC liquid content, 
but differed in their interpretations of the implications. The US FDA focused on the 
potential harm of the liquid contents to human health, whilst the HNZ focused on the 
relative risks of tobacco and ECs. In contrast, the Demokritos report focused mainly 
on the consumer experience, whilst maintaining a neutral position of the safety or 
efficacy of ECs.  
 
Unsurprisingly, given the growth of the EC market, and the nature of the emerging 
scientific evidence, reports and reviews of this nature were produced at an increasing 
rate and reflected the various ways in which the debate could be considered. 
Eissenberg (2010) reported, for example, that ECs were less effective in suppressing 
cravings than conventional cigarettes, raising further questions about whether ECs 
were the efficient replacement manufacturers claimed.  Bullen et al (2010) addressed 
the short term effect of an EC delivery on desire to smoke and on withdrawal, and 
suggested that ECs could be used as an aid to stopping smoking and had potential for 
long term use (Bullen et al., 2010). In 2011, the British Cabinet Office’s Behavioural 
Insights Team (BIT) endorsed tobacco harm reduction.  ECs were cited as 
potentially effective substitutes for tobacco that could save tens of thousands of lives 
(Stratton, 2011).  
 
2012 then saw position statements from consumer groups such as the Consumer 
Associate or Smoke Free Alternative Association (CASAA), Electronic Cigarette 
Consumer Association UK (ECCA UK), Stelda NL (Netherlands), and other 
European companies who also organized the first World Vaping Day, calling for 
their right to vape (CASSA, 2014). At the same time, questions were raised about the 
significance of passive vaping in the debate. Schripp, Markewitz, Uhde, and 
Salthammer (2013), for example, found that ECs do not produce second-hand smoke 
as conventional cigarettes do. Instead, bystanders are exposed to a mist of exhaled 
vapour, which undergoes changes in the human lungs similar to decomposition and 
evaporation (Schripp et al., 2013). This view positioned the rights of vapers and the 
rights of non-vaping bystanders directly in conflict.  By the end of 2012, several 
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studies concluded that ECs are safer when compared to tobacco smoking, and are an 
effective smoking cessation aid, see for example, (Bullen et al., 2010; Etter & 
Bullen, 2011; Flouris et al., 2012). Other studies raised caution, pointing to passive 
vaping, inconsistency with labelling, and questioning the long term benefit of 
vaping, see for example, (Eissenberg, 2010; Schripp et al., 2013).   
 
Between 2013 and 2016, emphasis on EC regulation grew, and tensions heightened 
as the tobacco industry became involved in the debates. Fierce scrutiny of evidence 
and arguments between stakeholder groups served to increase the degree of 
difference between stakeholders’ points of view just as, in January of 2013, the first 
television advert for ECs on a national, mainstream British channel was launched by 
E-Lites (Sweney, 2013).  In March 2013, the outcome of a public consultation to 
bring nicotine-containing products (NCPs), including ECs within the medicines 
licensing regime was published by the Medicines and Healthcare Products 
Regulatory Agency (MHRA). Medical and public health communities strongly 
supported regulating ECs under the medicines regulatory framework (MHRA, 2013). 
Those against the MHRA medical framework regulation were mainly importers and 
users of unlicensed electronic cigarettes who feared it could lead to a ban on 
available products, which would force EC users back into smoking tobacco (MHRA, 
2013).  
 
The Commission on Human Medicines (CHM) which advises the UK government 
on medicines then established an expert working group (MHRA, 2013). Three 
months later, the MHRA announced that the UK Government had decided that it 
would regulate all NCPs, including ECs, as medicines to ensure the safety of the 
product and to address the issue of distrust about the quality of some EC devices and 
their content. Thus, although some proponents of ECs considered them beneficial to 
public health, the policy stance adopted was that ECs were at that point, an 
inadequate intervention.   
 
The decision to regulate ECs in the same way as medical devices was taken to ensure 
that high quality products were made widely available and that smokers had an 
effective alternative. Regulation and marketing of ECs thus changed in ethos and 
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focus from a consumer product that was not subject to test before being put on sale to 
the public, to one which is regulated under the medicines regulatory framework, 
requiring manufacturers to apply for a medicinal licence from the Medicines and 
Healthcare products Regulatory Agency (MHRA).  
 
Later in 2013, British American Tobacco (BAT) and China National Tobacco 
Corporation jointly invested in a subsidiary (CTBAT International Limited) to launch 
their first EC product, Vype, in the UK (BAT, 2014).  In February of 2014, the 
European Parliament approved a revised European Union Tobacco Product Directive. 
This regulates ECs with more than 20 mg/Ml nicotine concentrations; a quantity 
equal to that in a pack of cigarettes (Gallagher, 2014) or with intended therapeutic 
use, following which they fell under the medical devices directives. The directive 
stipulated that ECs had to be childproof, packaging should have information relating 
to liquid composition, effects, with health warnings (EC, 2014).
  
 
Unsurprisingly, this was met with divergent views on the extent to which young 
people would be deterred from smoking (Gallagher, 2014), a divergence further 
fuelled by subsequent revisions to the Directive. Because of subsequent directives, 
advertising was prohibited for nicotine containing devices not licensed as medicines, 
health warnings are to be placed on all products and, data on nicotine uptake are to be 
provided subject to restrictions on total nicotine content. When used under normal 
conditions, suppliers are to take total responsibility for quality and safety (EC, 2014).  
Any EC that was not regulated by MHRA would be governed under the European 
Union Tobacco Products Directive (TPD) (EC, 2014). 
 
The on-going divide within the scientific and public health communities was clearly 
illustrated when, in 2014, 53 nicotine science specialists and public health policy 
experts wrote to Dr. Margaret Chan, of the World Health Organization (WHO). In 
the letter, they argue that regulating ECs similar to tobacco products would reduce 
the numbers of people relying on ECs to stop smoking and this, could potentially cost 
lives (Dreaper, 2014). They viewed ECs a significant step in health innovations made 
in the 21st century that could potentially save millions of lives. They asked WHO to 
resist the urge to control and suppress EC (Dreaper, 2014; Nicotinepolicy.net, 2014).  
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In response, 129 public health and medical experts from 31 countries of WHO 
region, signed a letter to Margaret Chan. This group of experts, in contrast, called for 
new controls on EC and warning of tobacco industry tactics (Aktan et al., 2014) and 
urging the WHO to be mindful of tobacco industry tactics in shaping arguments 
around EC regulation. 
 
Similar divisions and disagreement were played out in the UK. The British cabinet 
office were optimistic about the potential benefits of ECs as an effective aid to 
smoking cessation and offering a safer alternative to those who do not want to quit 
smoking. The Behavioural Insights Team (BIT, also known as the ‘Nudge Unit’) as 
early as 2011 endorsed ECs as potentially effective substitutes to tobacco (Stratton, 
2011), whereas other public institutions such as the British Medical Association 
(BMA), the UK Faculty of Public Health, and the European Commission took a 
precautionary stance and called for strict control and regulation of EC devices. They 
also expressed concern that ECs may be a potential gateway to re-normalizing 
smoking (Rigotti, 2015) and might be exploited by the tobacco industry (Kremer, 
2013). For example, the BMA raised concerns that ECs may re-normalise smoking, 
such that could undermine the smoking bans that helped de-glamorise tobacco in 
United Kingdom (Kremer, 2013). Other areas of contention included: inadequate 
safety controls to prevent accidental injury, monitoring of trends in dual use of EC in 
combination with continued tobacco smoking, regulation of marketing activity, and 
the involvement of the tobacco industry in the EC market. 
 
 
The EC Debate through a PERC Lens  
The central actors involved in the initial phase of the debate were:   
 the WHO, which raised the concern on the lack of evidence around the safety 
and efficacy of ECs; 
 
 the scientific community who are called upon to conduct more research in 
this arena; and 
 
 EC companies and retailers who claim that ECs are a safe alternative to 




The EC debate occurred in a social-political context where information and 
communication technologies (ICT) allow interactive and instant debate and where, in 
contrast to tobacco debates in the 1950s, there is more emphasis on citizens’ 
participation and deliberative policy making. The unfolding of events suggested a 
sharp divide within the scientific and public health communities in their 
interpretation of available evidence that mirrored a divide in the wider society. This 
illustrates Collingridge and Reeve’s (1986) over-critical model, where the science is 
contested and where multiple interpretations exist around available evidence. The 
core argument concerned the need to “get the regulatory framework right” for a 
device that could potentially save thousands of lives (Stratton, 2011); the need for 
more research to be done before any conclusions can be drawn (Smith, 2012); and 
the need to retain familiar habits and nicotine intake, to encourage cessation 
(CASSA, 2012). This period was marked at the end of 2012 by the entry of big 
tobacco companies into the electronic cigarette market creating tension and 
heightened scrutiny in the risk acceptability debate thereon. 
 
With reference to the PERC framework, the evolving events suggest that the 
institutional power of the WHO was significant in pointing out that the lack of 
knowledge about the safety and efficacy of ECs was important within the context of 
their declared public health benefit. The WHO’s call for research into the safety and 
efficacy of ECs seems to have driven scientific research around safety and efficacy. 
The MHRA-led public consultation on how to regulate ECs also influenced the 
direction of the vaping debate. This shifted the decision making power from the 
policy to the public domain, although this may have been a reflection of a more 
general shift towards democratic policy making in contemporary political life. In 
terms of expertise, the public relied on technical expertise to make sense of the 
benefits or risks of electronic cigarettes. This suggests that while the public were 
involved in decision-making relating to regulation; public engagement in the 
development of accepted knowledge around the safety and efficacy of ECs was 
limited to the acceptability debate with scientists playing leading role in the technical 
debate. The vaping debate also highlights how the presence or absence of trust could 
influence the nature of tension, and scrutiny of the debate around risk acceptability. 
For example, the entry of powerful tobacco companies in the EC industry fuelled 
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tension and suspicion, and further heightened scrutiny of evidence and arguments 
brought by stakeholders in the vaping risk debate. 
 
In the second examined phase of the vaping debate (the period between 2013 and 
2016), the entry of tobacco companies in the EC market saw more heightened 
tension and scrutiny of scientific evidence and interpretation. This created greater 
visibility for divisions and disagreements between the various stakeholders groups. 
Some of the situational factors that may have contributed to this scientific division 
and disagreement are: (a) the absence of economically resourced stakeholder groups 
before late 2012, (b) caution towards the use of delay tactics by EC companies in the 
same way as was seen in the tobacco debate, and (c) the fact that political power was 
less obvious earlier on in the technical debate relating to vaping. The results of the 
MHRA-led consultation were also published in this period. Medical and public 
health communities strongly supported the application of the medicines regulatory 
framework on ECs (MHRA, 2013). However, there were concerns on the part of 
marketers and users of unlicensed ECs that inappropriate regulation could lead to a 
ban on available products. Three months after the publication of the public 
consultation, the UK Government announced that all NCPs, including ECs, would be 
regulated as medicines and thereafter, the EU directive was adopted.  
 
With reference to the PERC framework, structural power can be seen to be 
expressed for instance in the stakeholder relation between expert committees and 
policy makers. For example, in 2015, shortly after the public health England’s expert 
conclusion that ECs are around 95% less harmful than smoking (McNeill et al., 
2015), the UK government made the decision that EC could be prescribed by NHS 
doctors to help smokers who wanted to quit smoking (Tonkin, 2015). Such a 
stakeholder relationship privileges this kind of technical expertise over other forms 
of expertise (e.g. experiential expertise) in the policy perspective taken to risk as it 
provides a platform for interaction and exchange of views with policy makers. 
Stakeholder relationships create power imbalances altering the degree of influence 




What was also important were how technical experts’ interpretations and frames of 
argument shaped the discourse around vaping risk. There were scientists and public 
health expert groups who viewed ECs as an effective aid to smoking cessation, and a 
safer alternative to those who do not want to quit smoking. On the other hand, there 
were those who called for a precautionary stance and for stricter control and 
regulation of EC devices. The latter group of experts expressed concern that ECs 
may be a potential gateway to renormalizing smoking, undermining several years of 
effort in deglamourizing smoking, and that ECs may be exploited by the tobacco 
industry to recruit non-smokers and children who may then go on to smoke 
cigarettes. The nature of interpretation is dependent on how the relative risks are 
judged, from the perspective of either the smokers or non-smokers. 
 
In terms of communication, one unique feature of this debate was how MHRA-led 
public consultation allowed a two-way communication between policy makers and 
the public, and how that has allowed different group of stakeholders to exchange 
views and opinions with policy makers. This may have eased public acceptability of 
EC regulation under the medical regime, as the public felt trusted and included in the 
decision as seen in the report of the consultation that shows a strong public support 
for medical consultation of ECs. The vaping debate also highlights the importance of 
(mis)trust in public health risk communication, around how the presence or absence 
of trust could influence the nature of tensions in, and scrutiny of the debate around 
risk acceptability. An important issue within this latter stage of the debate was how 
entrenched mistrust inherited from the smoking debate shaped the vaping debate. 
This was evidenced in the signed letter to Margaret Chan, of World Health 
Organisation – referred to earlier - that called for new regulation and control of ECs 
and expressed scepticism about the involvement of industry in public debate.  
 
Conclusions 
What will it take to protect public health risk communication within policy-related 
debates from a group of few influential people who may use opportunities within 
their reach for personal or group gains at the detriment of public health benefit? This 
question is pertinent where there is considerable uncertainty around the nature of the 
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risk and where vested interests combine with unequal status between stakeholders 
groups exist in a risk arena?  
 
Firstly, there is the need to ensure that policy makers, risk regulators, and 
stakeholder representatives engage in a more open and transparent process of risk 
identification, communication and validation. This is important if policy choices are 
to reflect public concerns that it serves. This could also be beneficial in easing 
tensions around public acceptability of risk and build the much needed trust 
relationship between all stakeholders in risk communication. The MHRA led public 
consultation on whether to regulate ECs as medical devices enabled different groups 
within the public to express their views and input into the UK government decision 
to: regulates EC as medical devices and NHS doctors to help smokers who wanted to 
quit smoking can prescribe. Such risk communication practices could potentially 
eliminate inequalities in the representations of the risks that are often amplified by 
privileged stakeholder’s relationship in the policy perspective taken to risk. Besides, 
relying too much on technical expertise neglects other forms of (experiential) 
expertise, thus, this reinforces potential misconceptions about the threats to public 
health and safety, especially if the dominant view is around the need for proof of 
harm rather than proof of safety.  
 
An alternative would be to take more a precautionary approach to dealing with the 
introduction of new forms of activity that may represent the potential for harm, 
although there are also challenges (e.g. over regulation) with such an approach 
(Calman & Smith, 2001; Fischbacher-Smith & Calman, 2010). In engaging the wider 
public, there is an opportunity to take advantage of recent advances in 
communication technology (e.g. social media) to share views, information, expertise 
and opinion and, to an extent, redistribute power associated with control of 
communication (Riedlinger & Rea, 2015).  
 
Secondly, academics have a responsibility to ensure the integrity of evidence that 
is relied upon for risk decisions. They must do more to interrogate new scientific 
evidence and challenge associated scientific assumptions that shape in particular, 
policy perspective taken to the risk. This was effectively illustrated in the e-cigarette 
debate where 129 public health and medical experts from 31 countries challenged the 
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arguments put forward by 53 nicotine science specialists and public health policy 
experts to WHO, saying that they should resist the urge to regulate ECs in the same 
manner as tobacco products (Dreaper, 2014). Such practices could potentially reduce 
the abuse of science for personal/group gains at the detriment of public health. It also 
creates an enabling environment where a balanced and robust science thrives, 
making it easy to discern science from political decisions. 
 
Academics must also do more to counter the enduring ideology that the experience 
and expertise of those in close proximity to the risk is anecdotal and therefore, bad 
science. Rather, they should adopt an approach where contrary experiences are 
valued and determine how facts and evidence relate with them (Brown, 2016). 
Furthermore, academics can do more to make scientific information more useable 
and accessible to different public audience to enable them participate fully in policy 
decisions that affect them. 
 
Thirdly, the media has a duty to ensure that there is unambiguous and balanced 
evidence based journalism and to ensure that this reflects the diversity of public 
concerns, more explicitly bringing these to the consciousness of experts, academics 
and politicians, and highlighting uncertainties where they exist. This is important in 
the social media age where it may be difficult to discern the differences between 
credible arguments from propaganda when dealing with public health risk issues or 
emergencies. Parents and educators also have a role here by ensuring that relevant 
skills such as critical thinking needed to evaluate the credibility of risk information 
are developed as early as possible. 
 
Finally, care must be taken in how risk issues are coded to avoid communication 
barriers (Bernstein, 2003). Framing risk agenda and asking clear risk questions with, 
and for the public, void of complexity, has the potential to encourage public 
engagement in the policy decision processes. This in the case of the MHRA led 
public consultation resulted in 1,217 responses from different public groups 
(including medical profession and consumer of NCPs) who were able comment and 
express their views in the policy decision process.  
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Conclusively, if we are to ensure that policy decisions relating to risk are not solely 
the product of powerful stakeholders who are able to shape the risk debate, there is a 
need to embrace what Irwin (2015) described as “contemporary knowledge 
relations” (p.10) where citizens as well as scientific and institutional organisations 
engage in critical reflection and reflection-informed practice. In this way, there is 
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